Cited by 159PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerTuberous Sclerosis Complex Research

REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling

Open access
Dennis, Michael D., Coleman, Catherine S., Berg, Arthur, Jefferson, Leonard S., Kimball, Scot R.·2014·Science Signaling

Abstract

The protein kinase mTOR (mechanistic target of rapamycin) in complex 1 (mTORC1) promotes cell growth and proliferation in response to anabolic stimuli, including growth factors and nutrients. Growth factors activate mTORC1 by stimulating the kinase Akt, which phosphorylates and inhibits the tuberous sclerosis complex [TSC; which is composed of TSC1, TSC2, and TBC1D7 (Tre2-Bub2-Cdc16 domain family member 7)], thereby stimulating the mTORC1 activator Rheb (Ras homolog enriched in brain). We identified the mechanism through which REDD1 (regulated in DNA damage and development 1) represses the mTORC1 signaling pathway. We found that REDD1 promoted the protein phosphatase 2A (PP2A)-dependent dephosphorylation of Akt on Thr(308) but not on Ser(473). Consistent with previous studies showing that phosphorylation of Akt on Thr(308), but not on Ser(473), is necessary for phosphorylation of TSC2, we observed a REDD1-dependent reduction in the phosphorylation of TSC2 and subsequently in the activation state of Rheb. REDD1 and PP2A coimmunoprecipitated with Akt from wild-type but not REDD1 knockout mouse embryonic fibroblasts, suggesting that REDD1 may act as a targeting protein for the catalytic subunit of PP2A. Furthermore, binding to both Akt and PP2A was essential for REDD1 to repress signaling to mTORC1. Overall, the results demonstrate that REDD1 acts not only as a repressor of mTORC1 but also as a constant modulator of the phosphorylation of Akt in response to growth factors and nutrients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scisignal.2005103

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PP2A participates in dephosphorylation of a large number of substrates in addition to tau and APP, such as p53, MEK, ERK, and Akt.

    “Furthermore, PP2A participates in dephosphorylation of a large number of substrates in addition to tau and APP, such as p53, mitogen-activated protein kinase (MEK), extracellular signal-regulated kinase (ERK), and Akt (Dennis et al., 2014; Junttila et al., 2007; Ugi et al., 2002).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dennis, M. D., Coleman, C. S., Berg, A., Jefferson, L. S., & Kimball, S. R.
Affiliations
Pennsylvania State University (US)
Corresponding author
Kimball, Scot R.
Venue
Science Signaling
Published
2014-07-22
Volume
7
Issue
335
Pages
ra68-ra68
ISSN
  • 1937-9145 (ISSN-L)
  • 1945-0877
OpenAlex
W1973310114
Cited by
159
References
52
Citations by year
2026: 14 · 2025: 11 · 2024: 8 · 2023: 9 · 2022: 16 · 2021: 12 · 2020: 12 · 2019: 11 · 2018: 18 · 2017: 13 · 2016: 16 · 2015: 11 · 2014: 8
FWCI
6.56
Type
journal article
Language
en
Open access
Locations
  • Science Signaling (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR000127)
  • National Eye Institute (EY-023612, R00EY023612, K99EY023612)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-15658, R01DK094141, R56DK094141, DK-094141, R01DK013499, R01DK015658, DK-13499.)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Physiology › Tuberous Sclerosis Complex Research
Keywords
REDD1, protein phosphatase 2A, Akt dephosphorylation, mTORC1 signaling, TSC2 phosphorylation, Akt Ser473 phosphorylation, tuberous sclerosis complex, growth factor signaling, nutrient signaling, cell growth and proliferation
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Animals, Fibroblasts, Humans, Phosphorylation, Transcription Factors, Signal Transduction, Mice, Knockout, Multiprotein Complexes, Proto-Oncogene Proteins c-akt, Mice, Protein Phosphatase 2, HEK293 Cells, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review